Company: AVCRF
Filing Date: 2025-06-16
Form Type: 20-F
Source: 0001641172-25-015266
Chunk: 65

Company: Avricore Health Inc.
Filing Date: 2025-06-16
Form: 20-F
Item: Item 19
Chunk 65
---
 operating activities                       1,004,615          660,403        ( 437,832  
  Investing Activities                                                                                                   
  Intangible assets                                                          ( 24,253         ( 25,288          ( 5,171  
  Purchase of equipment                                                     ( 181,094      ( 1,021,571      ( 1,193,345  
  Term deposit                                                                      -                -         ( 10,000  
  Net cash used in investing activities                                     ( 205,347      ( 1,046,859      ( 1,208,516  
  Financing Activities                                                                                                   
  Proceeds of exercise of warrants                                                  -                -          173,880  
  Proceeds from exercise of stock options                                      86,600           42,500           80,000  
  Loan repayments                                                            ( 30,000                -                -  
  Net cash provided by financing activities                                    56,600           42,500          253,880  
  Increase (decrease) in cash and cash equivalents                            855,868        ( 343,956      ( 1,392,468  
  Effects of foreign exchange translation on cash and cash equivalents           ( 47                -                   
  Cash and cash equivalents, beginning of year                                276,571          620,527        2,012,995  
  Cash and cash equivalents, end of year                                    1,132,392          276,571          620,527  

Supplemental
cash flow information (Note 15)

The accompanying notes are an integral part of these consolidated financial statements

  58  

Avricore
Health Inc.

Notes
to the Consolidated Financial Statements

For
the years ended December 31, 2024, 2023 and 2022

(Expressed
in Canadian Dollars)

  NATURE                           
  OF OPERATIONS AND GOING CONCERN  
 ───────────────────────────────────

Avricore
Health Inc. (the “ Company”) was incorporated under the Company Act

The
Company is involved in the business of health data and point-of-care technologies (“ POCT”).

The
consolidated financial statements have been prepared on the basis of accounting principles applicable to a going concern, which assumes
that the Company will continue in operations for the foreseeable future and be able to realize assets and satisfy liabilities in the
normal course of business. The availability of sufficient cash flows to fund the Company’s operations are